UMIN ID: UMIN000004102
Registered date:25/08/2010
Clinical Study of TM-Tibia/Patella
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Patients with knee pain and dysfunction who have been diagnosed to require knee replacement |
Date of first enrollment | 2004/06/01 |
Target sample size | 76 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Implantation of TM-Tibia/Patella by TKA |
Outcome(s)
Primary Outcome | (1)Efficacy evaluation Efficacy evaluation was performed using the following four categories of evaluation criteria based on the improvement rate by the JOA score and X-ray evaluation at 12 months postoperatively; Markedly effective, Effective, Slightly effective and Ineffective (2) Safety evaluation The clinical safety was evaluated based on the following four categories by comprehensively considering the adverse events; Safe, Almost safe, Insufficiently safe and Not safe (3) Usefulness evaluation The usefulness was judged according to the following five categories based on the matrix of efficacy and safety evaluation; Very useful, Useful,Slightly useful, Not useful and Contraindicated |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | (1)A patient with a previous history of infection in the affected joint. (2)A patient with insufficient bone stock on tibial, femoral or patellar surfaces. (3)A patient with a skeletal immaturity. (4)A patient with neuropathic arthropathy. (5)A patient with infection-like symptoms. (6)A patient with rheumatoid arthritis with a previous history of skin ulcer or recurrent skin breakdown. (7)A patient with osteoporosis or a neuromuscular disease that may compromise the affected limbs. (8)A patient with severe instability secondary to absence of a collateral ligament. (9)A patient who has been judged ineligible for the conduct of the study by the study investigator. |
Related Information
Primary Sponsor | Zimmer K.K. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Zimmer K.K. |
Secondary ID(s) |
Contact
public contact | |
Name | Mikio Ishikawa |
Address | 4-1-17 Toranomon, Minato-ku, Tokyo Japan |
Telephone | 03-6402-6671 |
Affiliation | Zimmer K.K. Clinical Affairs |
scientific contact | |
Name | Kenji Nakagawa, MD |
Address | 1-98 Dengakugakubo Kutsukake-cho Toyoake-shi, Aichi Japan |
Telephone | |
Affiliation | Former Fujita Health University Department of Orthopaedic Surgery |